Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
Status:
Completed
Trial end date:
2005-12-31
Target enrollment:
Participant gender:
Summary
What is the difference between the use of one drug (Oral Metronidazole) versus the use of
this same drug combined with another drug (Rifampin) in treatment of bacteria and
infection-associated diarrhea in patients? This infection is an important cause of morbidity
and mortality in both the community and hospitals, and the leading cause of hospital and
chronic facility-acquired diarrhea. Research is important for the treatment of this
infection. Patient care with use of two medication treatment regimens will be studied.